$59.18
0.49% day before yesterday
NYSE, May 30, 10:02 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$59.18
-12.59 17.54% 1M
-24.72 29.46% 6M
-23.53 28.45% YTD
-7.41 11.13% 1Y
-7.64 11.43% 3Y
+4.53 8.29% 5Y
+33.65 131.81% 10Y
NYSE, Closing price Fri, May 30 2025
+0.29 0.49%
ISIN
US3795772082
Symbol
GMED
Sector

Key metrics

Market capitalization $8.01b
Enterprise Value $7.55b
P/E (TTM) P/E ratio 44.16
EV/FCF (TTM) EV/FCF 14.59
EV/Sales (TTM) EV/Sales 3.01
P/S ratio (TTM) P/S ratio 3.19
P/B ratio (TTM) P/B ratio 1.96
Revenue growth (TTM) Revenue growth 32.26%
Revenue (TTM) Revenue $2.51b
EBIT (operating result TTM) EBIT $446.60m
Free Cash Flow (TTM) Free Cash Flow $517.59m
Cash position $461.27m
EPS (TTM) EPS $1.34
P/E forward 21.86
P/S forward 2.81
EV/Sales forward 2.65
Short interest 4.47%
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Globus Medical, Inc. Class A forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
63%
Hold
38%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,511 2,511
32% 32%
100%
- Direct Costs 832 832
16% 16%
33%
1,679 1,679
42% 42%
67%
- Selling and Administrative Expenses 975 975
27% 27%
39%
- Research and Development Expense 139 139
13% 13%
6%
565 565
126% 126%
23%
- Depreciation and Amortization 119 119
56% 56%
5%
EBIT (Operating Income) EBIT 447 447
157% 157%
18%
Net Profit 186 186
179% 179%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
GlobeNewsWire
17 days ago
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company's outstanding common stock.
Neutral
GlobeNewsWire
19 days ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
Seeking Alpha
24 days ago
Globus Medical, Inc. (NYSE:GMED ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Dan Scavilla - President & CEO Keith Pfeil - COO & CFO Conference Call Participants Matt Miksic - Barclays Vik Chopra - Wells Fargo Richard Newitter - Truist Securities Matthew Blackman - Stifel Shagun Singh - RBC Caitlin Cronin - Canaccord...
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,300
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today